ProCE Banner Activity

Applying Best Practices in Pain Management: Delivering Holistic Patient-Centered Care to Minimize Health Disparities and Adverse Opioid Outcomes

Slideset

Downloadable slideset covering pain management, including nonopioid and opioid approaches, and opioid use disorder identification and management. Slides may vary from specific presentations due to time constraints and primary presentation focus.

Released: December 07, 2023

Share

Faculty

Samantha Catanzano

Samantha Catanzano, PharmD, BCPP

Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Psychiatric Pharmacist
UT Health Austin, Dell Medical School
Austin, Texas

Theresa Mallick-Searle

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC

Adult Nurse Practitioner
Division of Pain Medicine
Stanford Healthcare
Redwood City, California

Ameet Nagpal

Ameet Nagpal, MD, MS, MEd, MBA

Professor, Department of Orthopedics & Physical Medicine
Division Chief, Physical Medicine & Rehabilitation
Medical University of South Carolina College of Medicine
Charleston, South Carolina

Jennifer Sorensen

Jennifer Sorensen, MSW, LSW, CPRS, CPS, DRCC

Social Worker

Dace Svikis

Dace Svikis, PhD

Professor
Department of Psychology
Virginia Commonwealth University
Richmond, Virginia

Amanda Zimmerman

Amanda Zimmerman, PA-C

Physician Assistant
West Forsyth Pain Management
Winston-Salem, North Carolina

Provided by

Provided by Clinical Care Options, LLC, and in partnership with Alliance to Advance Comprehensive Integrative Pain Management, American Academy of Physical Medicine and Rehabilitation and Practicing Clinicians Exchange, and ProCE.

ProCE Banner

Supporters

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA). 

Opioid Analgesic REMS Program Companies